• Astellas Pharma Acquires Potenza Therapeutics contractpharma
    December 18, 2018
    Astellas Pharma Inc. has exercised its exclusive option to acquire Potenza Therapeutics, Inc., paying $164.6 million upfront and additional payments of as much as $240.1 million, depending on the progress of various programs.
PharmaSources Customer Service